Skip to main content
Signal8

Bayer AG (BAYRY)

Sector: Drug Manufacturers - General

Industry: Drug Manufacturers - General

Bayer AG logo

Bayer AG

OTC:BAYRYHealthcare
AH+0.00%$15.91
Close$15.91+3.78%
Mkt Cap$62.52B
Float982.42M
O/S3.93B
VOL855K sh
$ Vol$13.49M
RVOL1.17×
Inst Own-
SI<0.1%
EarningsFeb 24 · in 4mo
Div Yield0.20%
Dilution
Bayer AG logoOTC:BAYRYAH$15.91+0.00%
Historical Data
DateOpenHighLowCloseVolume
Nov 9, 202615.6615.9715.5415.91933,290
Nov 6, 202615.0615.5515.0615.331,406,325
Nov 5, 202615.6715.8415.4815.521,656,068
Nov 4, 202615.1115.2514.9515.221,799,027
Nov 3, 202614.9715.0914.3914.41816,360
Nov 2, 202613.9414.0313.8613.95422,808
Oct 30, 202613.8914.0813.8013.99642,233
Oct 29, 202613.1113.3713.0913.37414,807
Oct 28, 202612.6512.8712.6412.80321,270
Oct 27, 202612.4712.8112.4712.80444,067
Oct 26, 202612.7212.7512.6512.69853,933
Oct 23, 202612.1912.3212.1112.30594,349
Oct 22, 202612.3012.4012.2812.40435,137
Oct 21, 202612.4312.5512.4212.49733,051
Oct 20, 202612.1512.2912.1312.21528,990
Oct 19, 202612.1912.2712.1212.12536,071
Oct 16, 202612.5112.5212.3912.47751,868
Oct 15, 202612.5912.6212.4112.42532,060
Oct 14, 202612.5012.6012.4112.54776,284
Oct 13, 202612.5012.5112.2712.33525,716
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
Not available
Ratings Distribution
BUY
1
HOLD
2
SELL
0
TOTAL3
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(15)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources: 13F
Insiders & Institutional Holders
About

Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries.

Its extensive operations are strategically segmented into Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division concentrates on developing and marketing prescription medications, with key areas including cardiology and women's healthcare.

It also offers specialized therapeutic solutions for oncology, hematology, and ophthalmology, alongside diagnostic imaging equipment, contrast agents, and advanced cell and gene therapies. Bayer's Consumer Health segment provides a wide array of non-prescription (over-the-counter) medicines, medical devices, medicated skincare items, and nutritional supplements. These self-care products address diverse health needs such as dermatology, dietary support, pain relief, cardiovascular risk prevention, digestive issues, allergy management, and cold and cough symptoms. The Crop Science division supports the agricultural sector with chemical and biological crop protection products, genetically enhanced plant traits, seeds, digital farming tools, and solutions for pest and weed control. This segment also manages the breeding, propagation, production, and specialized treatment of seeds, complemented by dedicated customer service for farmers. Bayer is actively involved in numerous strategic collaborations to bolster its research and development pipeline. These partnerships include an agreement with MD Anderson Cancer Center for oncology drug development, a research and licensing deal with Dewpoint Therapeutics, Inc. focused on novel treatments for cardiovascular and gynecological diseases, and collaborations with Exscientia Ltd, Foundation Medicine Inc., Evotec AG, and Arvinas Inc.

Additionally, the company maintains strategic research alliances with the University of Oxford for gynecological therapies and with Kyoto University to discover potential new drugs for pulmonary conditions.

The company’s products reach a broad market through various distribution channels, including wholesale partners, independent and chain pharmacies, supermarkets, online and other retail outlets, hospitals, and direct sales to agricultural producers. Bayer Aktiengesellschaft was established in 1863 and is headquartered in Leverkusen, Germany.

Key Metrics
Market Cap$62.52B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 3.93B shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - General
ExchangeOTC
CountryDEDE
IPO DateNov 18, 1996
Shares Outstanding3.93B
Authorized Shares
Float982.42M
52-Week Range
$7.56$15.97
$15.91(99th percentile)
Volume
Average Daily Volume751.84K
933.29K today vs 751.84K avg(+24%)

30d Avg

751.84K

60d Avg

661.47K

90d Avg

572.89K

Earnings
Dividend History
TTM Yield
0.20%
Paid annually
Annual (LTM)
$0.03
Latest
$0.0321
Apr 28, 26
5Y Growth
-44.40%
per year
Compliance Status
Loading compliance data...